Mr. Raj Grover reports

HIGH TIDE ANNOUNCES PRELIMINARY Q3 2026 GUIDANCE

High Tide Inc. has released guidance estimates regarding anticipated results for its third fiscal quarter ended July 31, 2026.

"This quarter's guidance demonstrates the growing earnings power of the global platform we have built. We expect to set new company records for revenue, gross profit and adjusted EBITDA [earnings before interest, taxes, depreciation and amortization], with year-over-year growth of at least 30 per cent, 27 per cent and 43 per cent, respectively. Importantly, even the low end of our guidance exceeds the highest current analyst estimate across all three metrics. We believe this provides clear evidence that current market expectations have not yet caught up with the strength, scale and operating leverage of our business," said Raj Grover, founder and chief executive officer of High Tide.

"Our performance is being driven by two increasingly powerful growth engines. In Canada, our bricks-and-mortar business returned to positive year-over-year same-store sales in June and remained positive in July, which we believe compares favourably with broader market trends and reinforces the resilience of our discount-club model. In Germany, Remexian achieved another all-time quarterly distribution record, shipping over 10 tonnes of medical cannabis, an increase of 33 per cent sequentially, 60 per cent year over year. Together, these results demonstrate that our Canadian retail platform is strengthening while our German medical cannabis business is scaling rapidly, creating a more diversified and increasingly profitable global enterprise," added Mr. Grover.

The company anticipates releasing full financial and operational results for the third fiscal quarter ended July 31, 2026, on Monday, Sept. 14, 2026, after markets close, with a conference call the following morning.

About High Tide Inc.

High Tide is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide is uniquely built around the cannabis consumer, with wholly diversified and fully integrated operations across all components of cannabis, including:

• Retail: Canna Cabana is the largest cannabis retail chain in Canada, with 229 domestic and one international location. The company's Canadian brick-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, holding a growing 12-per-cent share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD (cannabidiol) products. In 2025, the company became the first North American cannabis operator to launch a brick-and-mortar presence in Germany.
• Medical cannabis distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14-per-cent share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries, including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by The Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX-V in 2022, 2024 and 2025. High Tide was also ranked No. 1 in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023.

We seek Safe Harbor.